vegf protein Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Cell Signaling Technology Inc vegfr2
    CLEC14A deficiency attenuates VEGFR-3 expression, promotes <t>VEGFR-2</t> expression, and forms a CLEC14A–VEGFR-3 complex via the CLEC14A cytosolic domain in ECs.
    Vegfr2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vegfr2/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vegfr2 - by Bioz Stars, 2021-04
    99/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human vegf a
    CLEC14A deficiency attenuates VEGFR-3 expression, promotes <t>VEGFR-2</t> expression, and forms a CLEC14A–VEGFR-3 complex via the CLEC14A cytosolic domain in ECs.
    Recombinant Human Vegf A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf a/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    recombinant human vegf a - by Bioz Stars, 2021-04
    94/100 stars
      Buy from Supplier

    98
    R&D Systems recombinant human vegf165
    CLEC14A deficiency attenuates VEGFR-3 expression, promotes <t>VEGFR-2</t> expression, and forms a CLEC14A–VEGFR-3 complex via the CLEC14A cytosolic domain in ECs.
    Recombinant Human Vegf165, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf165/product/R&D Systems
    Average 98 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    recombinant human vegf165 - by Bioz Stars, 2021-04
    98/100 stars
      Buy from Supplier

    N/A
    Purified recombinantMurine VEGF protein
      Buy from Supplier

    N/A
    Mouse Vascular Endothelial Growth Factor 120 Recombinant Protein 010 001 W36 0100
      Buy from Supplier


    N/A
    VEGF is a potent growth and angiogenic cytokine It stimulates proliferation and survival of endothelial cells and promotes angiogenesis and vascular permeability Expressed in vascularized tissues VEGF plays a prominent
      Buy from Supplier

    Image Search Results


    CLEC14A deficiency attenuates VEGFR-3 expression, promotes VEGFR-2 expression, and forms a CLEC14A–VEGFR-3 complex via the CLEC14A cytosolic domain in ECs.

    Journal: The Journal of Clinical Investigation

    Article Title: Carbohydrate-binding protein CLEC14A regulates VEGFR-2– and VEGFR-3–dependent signals during angiogenesis and lymphangiogenesis

    doi: 10.1172/JCI85145

    Figure Lengend Snippet: CLEC14A deficiency attenuates VEGFR-3 expression, promotes VEGFR-2 expression, and forms a CLEC14A–VEGFR-3 complex via the CLEC14A cytosolic domain in ECs.

    Article Snippet: The following primary antibodies were used: CD31 (BD Pharmingen; catalog 550274); NG-2 (EMD Millipore; catalog ab5320); CLEC14A (R & D Systems, catalog AF4968; Santa Cruz Biotechnology Inc., catalogs sc-246295 and sc-246296; Abcam, catalog Ab73087); MMRN2 (Santa Cruz Biotechnology Inc.; catalog sc-54120); LYVE-1 (AngioBio; catalog 11-034); VEGFR-2 (Cell Signaling Technology; catalog 2479); p–VEGFR-3 (Cell Applications Inc.; catalog CY1115); VEGFR-3 (R & D Systems, catalogs AF349 for human and AF743 for mouse; Santa Cruz Biotechnology Inc., catalog sc321); collagen type IV (Cosmo Bio; catalog LSL-LB-1407); PH3 (EMD Millipore; catalog 66-570); FITC (catalog FD40S), α-SMA (catalog F3777), X-gal (catalog 7240-90-6), and DAPI (catalog D9542) (Sigma-Aldrich); EEA1 (Santa Cruz Biotechnology Inc.; catalog sc-33585); β-actin (Thermo Fisher Scientific; catalog MA5-15739); and phosphorylated eNOS (p-eNOS), eNOS, p–VEGFR-2, VEGFR-2, p-ERK, and ERK (Cell Signaling Technology; catalogs 9571, 9572, 2478, 2479, 9106, and 9102).

    Techniques: Expressing

    Silencing or overexpression of CLEC14A regulates the phosphoactivation of VEGFR-3 and VEGFR-2 and their downstream signaling upon stimulation with VEGF-C or VEGF-A in HDBECs.

    Journal: The Journal of Clinical Investigation

    Article Title: Carbohydrate-binding protein CLEC14A regulates VEGFR-2– and VEGFR-3–dependent signals during angiogenesis and lymphangiogenesis

    doi: 10.1172/JCI85145

    Figure Lengend Snippet: Silencing or overexpression of CLEC14A regulates the phosphoactivation of VEGFR-3 and VEGFR-2 and their downstream signaling upon stimulation with VEGF-C or VEGF-A in HDBECs.

    Article Snippet: The following primary antibodies were used: CD31 (BD Pharmingen; catalog 550274); NG-2 (EMD Millipore; catalog ab5320); CLEC14A (R & D Systems, catalog AF4968; Santa Cruz Biotechnology Inc., catalogs sc-246295 and sc-246296; Abcam, catalog Ab73087); MMRN2 (Santa Cruz Biotechnology Inc.; catalog sc-54120); LYVE-1 (AngioBio; catalog 11-034); VEGFR-2 (Cell Signaling Technology; catalog 2479); p–VEGFR-3 (Cell Applications Inc.; catalog CY1115); VEGFR-3 (R & D Systems, catalogs AF349 for human and AF743 for mouse; Santa Cruz Biotechnology Inc., catalog sc321); collagen type IV (Cosmo Bio; catalog LSL-LB-1407); PH3 (EMD Millipore; catalog 66-570); FITC (catalog FD40S), α-SMA (catalog F3777), X-gal (catalog 7240-90-6), and DAPI (catalog D9542) (Sigma-Aldrich); EEA1 (Santa Cruz Biotechnology Inc.; catalog sc-33585); β-actin (Thermo Fisher Scientific; catalog MA5-15739); and phosphorylated eNOS (p-eNOS), eNOS, p–VEGFR-2, VEGFR-2, p-ERK, and ERK (Cell Signaling Technology; catalogs 9571, 9572, 2478, 2479, 9106, and 9102).

    Techniques: Over Expression

    VEGFR-2 inhibitors suppress tumor growth, increase the number of functional vessels, and improve the survival of tumor-bearing CLEC14A-KO mice.

    Journal: The Journal of Clinical Investigation

    Article Title: Carbohydrate-binding protein CLEC14A regulates VEGFR-2– and VEGFR-3–dependent signals during angiogenesis and lymphangiogenesis

    doi: 10.1172/JCI85145

    Figure Lengend Snippet: VEGFR-2 inhibitors suppress tumor growth, increase the number of functional vessels, and improve the survival of tumor-bearing CLEC14A-KO mice.

    Article Snippet: The following primary antibodies were used: CD31 (BD Pharmingen; catalog 550274); NG-2 (EMD Millipore; catalog ab5320); CLEC14A (R & D Systems, catalog AF4968; Santa Cruz Biotechnology Inc., catalogs sc-246295 and sc-246296; Abcam, catalog Ab73087); MMRN2 (Santa Cruz Biotechnology Inc.; catalog sc-54120); LYVE-1 (AngioBio; catalog 11-034); VEGFR-2 (Cell Signaling Technology; catalog 2479); p–VEGFR-3 (Cell Applications Inc.; catalog CY1115); VEGFR-3 (R & D Systems, catalogs AF349 for human and AF743 for mouse; Santa Cruz Biotechnology Inc., catalog sc321); collagen type IV (Cosmo Bio; catalog LSL-LB-1407); PH3 (EMD Millipore; catalog 66-570); FITC (catalog FD40S), α-SMA (catalog F3777), X-gal (catalog 7240-90-6), and DAPI (catalog D9542) (Sigma-Aldrich); EEA1 (Santa Cruz Biotechnology Inc.; catalog sc-33585); β-actin (Thermo Fisher Scientific; catalog MA5-15739); and phosphorylated eNOS (p-eNOS), eNOS, p–VEGFR-2, VEGFR-2, p-ERK, and ERK (Cell Signaling Technology; catalogs 9571, 9572, 2478, 2479, 9106, and 9102).

    Techniques: Functional Assay, Mouse Assay